ARTICLE
15 February 2015

Australian High Court to consider the patentability of isolated genes

SF
Spruson & Ferguson

Contributor

Established in 1887, Spruson & Ferguson is a leading intellectual property (IP) service provider in the Asia-Pacific region, with offices in Australia, China, Indonesia, Malaysia, Philippines, Singapore, and Thailand. They offer high-quality services to clients and are part of the IPH Limited group, which includes various professional service firms operating under different brands in multiple jurisdictions. Spruson & Ferguson is an incorporated entity owned by IPH Limited, with a strong presence in the industry.
Friday the 13th proved lucky for those opposed to gene patents in Australia.
Australia Intellectual Property

Friday the 13th proved lucky for those opposed to gene patents in Australia with the High Court (equivalent to the US Supreme Court) granting a special leave application to appeal the decision of the Full Court of the Federal Court, which unanimously confirmed the patentability of isolated genes in Australia. Commentary in relation to the Full Court decision can be found here.

Today's decision means that the High Court will provide a definitive judgment in relation to the patentability of isolated genes in Australia, which the lower courts have unanimously found to be patentable.

A decision from the High Court is expected sometime this year and Shelston IP will keep you updated in this regard.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More